A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies
| Image |  |
|---|---|
| Description | scientific article published on 19 September 2019 |
| Author/s |
author: Filipa Lynce |
| Publication date | September 19, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |